Precigen, Inc. (NASDAQ:PGEN) Q1 2026 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the Precigen First Quarter 2026 Financial Results and Business Update Conference Call.
Precigen Inc. (PGEN)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Patient Capital Management Samantha Mclemore | 17,817,387 | $68,953,288 | -5% | 2.52% |
| 2. | Iridian Asset Management David Cohen And Harold Levy | 3,592,730 | $13,903,865 | -1% | 5.64% |
| 3. | Boxer Capital Aaron Davis And Christopher Fuglesang | 3,500,000 | $13,545,000 | +155% | 1.78% |
| 4. | Woodline Partners Michael Rockefeller And Karl Kroeker | 1,401,412 | $5,423,464 | +1% | 0.02% |
| 5. | Springbok Capital Gavin Saitowitz And Cisco J. Del Valle | 1,270,053 | $4,915,105 | +96% | 0.38% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.40 | 2,000 | $6,800.00 | 405,959 | 2025-09-26 | Filing | |
| $3.58 | 6,000 | $21,480.00 | 65,031 | 2025-09-29 | Filing | |
| $3.42 | 2,932 | $10,027.44 | 468,626 | 2025-09-26 | Filing | |
| $3.62 | 8,284 | $29,988.08 | 465,694 | 2025-09-25 | Filing | |
| $4.60 | 15,000 | $69,000.00 | 217,841 | 2025-09-04 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.30 | 2,334,420 | $7,703,586.00 | 12,262,741 | 2026-03-30 | Filing | |
| $3.30 | 23,789 | $78,503.70 | 423,984 | 2026-03-30 | Filing | |
| $3.30 | 38,976 | $128,620.80 | 302,213 | 2026-03-30 | Filing | |
| $3.30 | 47,101 | $155,433.30 | 519,061 | 2026-03-30 | Filing | |
| $3.30 | 168,794 | $557,020.20 | 1,425,544 | 2026-03-30 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 15,223,191 | $58,913,751 | 0% | |
| 2. | 7,148,996 | $27,666,615 | 0% | |
| 3. | 2,633,780 | $10,192,728 | 0% | |
| 4. | 2,116,011 | $8,188,963 | 0% | |
| 5. | 1,821,790 | $7,050,327 | 0% |
News See All
Is Precigen, Inc. (PGEN) A Good Stock To Buy Now?
Is PGEN a good stock to buy? We came across a bullish thesis on Precigen, Inc. on Valueinvestorsclub.com by coalone. In this article, we will summarize the bulls’ thesis on PGEN.
9 Best Healthcare Penny Stocks to Buy According to Hedge Funds
Volatility in the equity market has been on another level in the first quarter of the year.
8 Best Rising Penny Stocks to Buy Now
On April 1, Francis Gannon, Co-Chief Investment Officer and Managing Director of Royce Investment, released his Q1 2026 small-cap recap report.
10 Best Multibagger Penny Stocks to Invest In
Small-cap and penny stocks are often overlooked by Wall Street as they tend to be extremely volatile.
Precigen, Inc. (NASDAQ:PGEN) Q4 2025 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the Precigen, Inc. Full Year 2025 Financial Results and Business Updates Conference Call.
Precigen (PGEN) Surged Following the Early Approval of Papziemos
Patient Capital Management, a value investing firm, released its “Patient Opportunity Equity Strategy” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Precigen, Inc. (PGEN) Builds Commercial Stage With Global Regulatory Support
Precigen Inc. (NASDAQ:PGEN) is one of Goldman Sachs’ top penny stock picks. On January 20, Precigen Inc.
Goldman Sachs Penny Stocks: Top 12 Stock Picks
The rotation towards small and micro-cap stocks is gaining momentum.
Precigen, Inc. (NASDAQ:PGEN) Q3 2025 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the Precigen Third Quarter 2025 Financial Results and Business Updates Conference Call. At this time, all lines are in listen-only mode.
Hedge Fund Resource Center